Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 228 Carcinoma, Intraductal, Noninfiltrating 19 Breast Carcinoma In Situ 15 Neoplasm Metastasis 13 Neoplasms 11 Breast Neoplasms, Male 11 Ovarian Neoplasms 8 Inflammatory Breast Neoplasms 6 Glioblastoma 5 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Prostatic Neoplasms 3 Obesity 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Breast Cancer Female 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Sleep Wake Disorders 2 Recurrence 2 Multiple Endocrine Neoplasia Type 1 2 Hot Flashes 2 Glioma 2 Fibroadenoma 2 ER+ Breast Cancer 2 Astrocytoma 2 Vitamin D Deficiency 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1

Interventions

Cisplatin 143 Radiotherapy 67 Brachytherapy 62 Paclitaxel 61 Carboplatin 58 pembrolizumab 52 Bevacizumab 33 Colposcopy 27 Gemcitabine 26 Surveys and Questionnaires 24 Radiation 23 Topotecan 22 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 22 Papillomavirus Vaccines 19 human papillomavirus vaccine, L1 type 16, 18 18 Nivolumab 18 Magnetic Resonance Spectroscopy 18 Blood Specimen Collection 17 Drug Therapy 16 Biopsy 16 Platinum 15 Cyclophosphamide 15 Radiotherapy, Intensity-Modulated 14 Docetaxel 14 atezolizumab 13 fludarabine 12 Vaccines 12 Taxes 12 Papanicolaou Test 12 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02482740 2015-06-26

TGOG1005

Buddhist Tzu Chi General Hospital

Phase 2 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡